Drug improves cognitive function in mouse model of Down syndrome
An existing FDA-approved drug improves cognitive function in a mouse model of Down syndrome, according to a new study.
View full story
Post your comment.
Retinoids may increase effectiveness of targeted therapies against high-risk leukemia
Air pollution linked to children's low academic achievement
Turning breath into words: New device unveiled to give paralysis victims a voice
Neurobiology: Light-activated learning
Glial cells use lipids to direct neuron organization in the spinal cord
Degenerating neurons respond to gene therapy treatment for Alzheimer's disease
Massive study reports challenges in reproducing published psychology findings
Four-day school week can improve academic performance, study finds
Cannabis and the brain
Awareness of memory loss may decline two-three years before dementia onset